RE:RE:RE:RE:RE:An additional 1,378,843 shares of common stock may be ....LOL TTG, I assume you are in the US by your MEDIF referal and until we hear from Medipharm your speculation / assumptions hold no weight. No one but the insiders know exactly what the terms are!
Depending on which analysts you follow, Tilray could enjoy near term success and Medipharm's holding of TLRY shares could be quite lucrative. They are not in need of immediate cash, so I guess we will see which way they go soon enough. I personally hope they hang on for a healthy uptick that will be associated with the SAFER Banking Act and rescheduling, but first the US government needs to get their House in order to get moving forward.
There is still additional info required relating to the product TLRY is giving LABS as part of the settlement as well, so lets see what they have to say, before assuming anything, as the fact is we dont know............